We identify, acquire, develop, and commercialize "first in class" innovative and novel treatments for cancer.
We have deep experience in biotherapeutic manufacturing, research, development, finance and operations. We partner with industry collaborators and academic institutions to rapidly and efficiently complete research and development activities.
Innovatrx has a standard overhead rate equal to that of the American Cancer Society, currently 20%.
Copyright © 2022 Innovatrx - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.